aTyr Pharma, Inc. (ATYR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for aTyr Pharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.98x | -4.20x | -1.84x | -1.08x | -0.98x | -0.98x |
| P/B Ratio | 1.08x | 3.84x | 1.02x | 0.69x | 0.30x | 0.50x |
| P/S Ratio | 383.25x | 1143.94x | 262.72x | 4.73x | 0.00x | 1.52x |
| Profitability | ||||||
| Gross Margin | -717.4% | 100.0% | 100.0% | 83.7% | 0.0% | -65.4% |
| Operating Margin | -40856.3% | -28899.6% | -15557.8% | -446.8% | 0.0% | -152.2% |
| Net Margin | -39009.5% | -27243.8% | -14274.5% | -436.5% | 0.0% | -155.2% |
| EBITDA Margin | -40038.9% | -28244.3% | -14781.3% | -430.5% | 0.0% | -140.1% |
| Liquidity | ||||||
| Current Ratio | 5.30x | 5.48x | 6.27x | 5.83x | 18.89x | 6.06x |
| Quick Ratio | 5.30x | 5.48x | 6.27x | 5.83x | 18.89x | 6.06x |
| Leverage | ||||||
| Debt/Equity | 0.18x | 0.19x | 0.17x | 0.16x | 0.01x | 0.07x |
YoY = year-over-year change. Source: FMP..